Under the leadership of Anne Milgram, DEA Administrator, the agency has intensified its fight against the fentanyl epidemic. In 2023, nearly 500 overdose-related investigations were launched through ...
Shares of cannabis stocks slumped after a company set to testify in the Drug Enforcement Administration's rescheduling hearings accused the agency of obstructing the rulemaking process.